Current Drug Targets

SJR Rank #7,885H-index: 129SJR: 0.726Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Bentham Science Publishers

Country

United Arab Emirates

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Clinical BiochemistryQ2
  • Drug DiscoveryQ2
  • PharmacologyQ2
  • Molecular MedicineQ3

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Computational Drug Discovery MethodsCancer Mechanisms and TherapyInflammatory Bowel DiseaseDiverse Scientific and Economic StudiesNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery14-3-3 protein interactionsCholinesterase and Neurodegenerative DiseasesMicroRNA in disease regulationReceptor Mechanisms and Signaling

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs070140210280

Documents per Year

202220250306090120

Detailed Information

ISSN

1873-5592, 1389-4501

SJR Best Quartile

Q2

Region

Middle East

Citations per Document (2 years)

3.49

References per Document

118.01

Coverage

2000-2026

Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Metrics from SCImago Journal Rank 2025. View on SCImago